0.4021

4.99% 0.0191

Bioaffinity Technologies Inc (BIAF)

Overview News Price History Financials Discussions Forecast

Bioaffinity Technologies Inc stock is traded at $0.4021, with a volume of 475.94K. It is up +4.99% in the last 24 hours and down -43.32% over the past month. bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Previous Close:

$0.383

Open:

$0.39

24h Volume:

475.94K

Relative Volume:

1.25

Market Cap:

$2.73M

Revenue:

$5.66M

Net Income/Loss:

$-15.88M

P/E Ratio:

-0.0355

EPS:

-11.3134

Net Cash Flow:

$-10.93M

1W Performance:

-21.16%

1M Performance:

-43.32%

6M Performance:

-61.34%

1Y Performance:

-94.75%

1-Day Range:

$0.3855

$0.4137

1-Week Range:

$0.3252

$0.52

52-Week Range:

$0.3252

$13.50

Bioaffinity Technologies Inc Stock (BIAF) Company Profile

Name

Bioaffinity Technologies Inc

Sector

Healthcare (1080)

Industry

Diagnostics & Research (50)

Phone

210-698-5334

Address

3300 NACOGDOCHES ROAD, SAN ANTONIO

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BIAF's Discussions on Twitter

Compare BIAF vs TMO, DHR, NTRA, IDXX, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIAF Bioaffinity Technologies Inc	0.4021	3.21M	5.66M	-15.88M	-10.93M	-11.31
TMO Thermo Fisher Scientific Inc	588.29	222.96B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	202.45	144.67B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	309.93	45.54B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	550.96	44.95B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.53	41.87B	7.23B	1.41B	1.09B	4.979

Bioaffinity Technologies Inc Stock (BIAF) Latest News

Aug 14, 2026

bioAffinity Technologies closes $4M private placement - Investing.com

Aug 14, 2026

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - PR Newswire

Aug 14, 2026

BioAffinity Technologies Closes $4 Million Private Placement - marketscreener.com

Aug 14, 2026

bioAffinity Technologies closes $4M private placement By Investing.com - Investing.com Canada

Aug 14, 2026

bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

bioAffinity Technologies prices $4M private placement offering - Investing.com

Aug 13, 2026

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - PR Newswire

Aug 13, 2026

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - Business Wire

Aug 13, 2026

Aug 10, 2026

bioAffinity Technologies to Add Mexican Patent to its CyPath Lung Technology IP - Medical Product Outsourcing

Aug 10, 2026